Pulse Biosciences, Inc. (PLSE) Misses Q1 EPS by 6c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $444 thousand versus the consensus estimate of $710 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss